Results 231 to 240 of about 14,856,428 (285)
A Finnish nationwide population-based study on the survival of patients with peripheral T-cell lymphoma. [PDF]
Reunamo T +7 more
europepmc +1 more source
Population Pharmacokinetics of Valemetostat and Exposure-Response Analyses of Efficacy and Safety in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma. [PDF]
Inoue H +7 more
europepmc +1 more source
Cure of a CD20-positive peripheral T-cell lymphoma-NOS with CHOPE regimen plus surgery a case report and literature review. [PDF]
Chi C, Wang S, Xu M, Shi Y, Ran X.
europepmc +1 more source
Nodal Peripheral T-Cell Lymphoma: Therapeutic Challenges and Future Perspectives. [PDF]
Lam HPJ, Amin F, Arulogun SO, Gleeson M.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematological Oncology, 2023
AbstractThe treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients?
Broccoli A., Zinzani P. L.
openaire +3 more sources
AbstractThe treatment of peripheral T‐cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T‐cell lymphoma patients?
Broccoli A., Zinzani P. L.
openaire +3 more sources
Cancer and Metastasis Reviews, 1988
Since the discovery of human T-cell leukemia virus type 1 (HTLV-1) in patients with adult T-cell leukemia/lymphoma (ATLL), malignant neoplasms of mature (peripheral) T lymphocytes have attracted a great deal of attention. This type of neoplasm is more common in Japan than in Western countries, and may show distinct clinical pictures such as ...
S, Watanabe, K, Mukai, M, Shimoyama
openaire +2 more sources
Since the discovery of human T-cell leukemia virus type 1 (HTLV-1) in patients with adult T-cell leukemia/lymphoma (ATLL), malignant neoplasms of mature (peripheral) T lymphocytes have attracted a great deal of attention. This type of neoplasm is more common in Japan than in Western countries, and may show distinct clinical pictures such as ...
S, Watanabe, K, Mukai, M, Shimoyama
openaire +2 more sources
The spectrum of peripheral T-cell lymphomas
Current Opinion in Hematology, 2009This review summarizes recent progress that has advanced our understanding of the pathobiology and prognosis of peripheral T-cell lymphomas including the changes introduced to the updated World Health Organization classification of lymphoid neoplasms.The International Peripheral T-Cell Lymphoma Project was a large collaborative project, highlighting ...
Hilary, O'leary, Kerry J, Savage
openaire +2 more sources
Peripheral T Cell Lymphoma: an Overview
Leukemia & Lymphoma, 1990Peripheral T cell lymphoma (PTCL) is a term that encompasses a wide range of histological subtypes of Non-Hodgkin's lymphoma which arise from mature or post-thymic T lymphocytes. These tumours account for 10-20% of all cases of non-Hodgkin's lymphoma in the Western World.
P A, Hall, M A, Richards
openaire +2 more sources
Peripheral T-Cell Lymphoma of the Scrotum
Acta Haematologica, 2009Primary lymphoma of the scrotum is rare. We report a case of primary immunoblastic lymphoma of the scrotum in a homosexual who was negative for antibodies to human immunodeficiency virus. Immunoperoxidase stains of paraffin-embedded tissue were consistent with a T-cell phenotype.
D C, Doll, A A, Diaz-Arias
openaire +2 more sources
Romidepsin for peripheral T-cell lymphoma
Expert Review of Hematology, 2013Peripheral T-cell lymphoma (PTCL) is comprised of a rare heterogeneous group of diseases with diverse clinical presentations; however outcomes associated with conventional chemotherapy are generally poor in the majority of patients. Newer approaches, which include dose-intensification and agents with novel mechanisms of action, are needed to improve ...
Amit, Khot +2 more
openaire +2 more sources

